Zimmer Highlights Advancements in Reconstructive and Trauma Offerings at 11th EFORT Congress in Madrid, Spain

Clinical Success and Product Innovations Headline Zimmer Presentation Schedule

MADRID, June 2, 2010 - Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal
care, today announced its presentation schedule for the 11th annual EFORT
(European Federation of National Associations of Orthopaedics and
Traumatology) Congress, highlighting advancements in its Reconstructive and
Trauma offerings. Zimmer will be presenting three side events throughout the
EFORT Congress to be held June 2-5, 2010 in Madrid, Spain.

"Recon Innovations in the New Decade" will introduce European surgeons to
the latest Zimmer Reconstructive products. The discussion will focus on:
Trabecular Metal(TM) Technology in Knee revisions; the Fitmore(R) Hip Stem,
whose three different stem families and four offset options provide for a
more accurate reconstruction of patient anatomy; and a presentation focused
on Shoulder Systems. This session will be held on June 2.

On June 3, "Integrated Taper Cup Systems" will include a discussion of
the recently launched Allofit(R) IT, Continuum(TM) and Trilogy(R) IT
Acetabular Systems, all of which incorporate proven fixation technologies and
an integrated taper design to give surgeons a wide range of advanced bearing
options to better match the demands of individual patients.

Zimmer's third presentation, "Zimmer Natural Nail," will introduce
attendees to the Zimmer(R) Natural Nail(TM) System through a demonstration
and discussion. The Zimmer Natural Nail System is a next-generation line of
intramedullary nails, screws, instruments and other associated implants
designed to provide stable fixation for long bone fractures and help restore
the shape of fractured bone to its natural, pre-injured state. The session
will be held on June 4.

The new Zimmer Natural Nail portfolio will not only be presented at the
side event, but can also be seen at the Zimmer booth. Zimmer will also be
highlighting the performance of its Zimmer(R) NexGen(R) Primary Knees, which
have outranked other primary knee implants(1) in the Swedish Knee
Arthroplasty Registry in the last consecutive five annual reports covering 14
years of revision data. The full Integrated Taper Cup Systems Portfolio will
also be presented at the booth. The newly available enhanced instruments for
Zimmer's Anatomical Shoulder(TM) System, which are designed for optimal ease
of use and precision, are available as well.

"The EFORT Congress is the ideal platform to spotlight the latest
developments in Zimmer Reconstructive and Trauma products to European
surgeons and we're particularly excited about this year's presentation
schedule," said Katarzyna Mazur, Senior Vice President, Sales and Marketing,
EMEA and General Manager, Zimmer GmbH. "These presentations are also a great
forum for interacting with surgeons. Zimmer seeks and welcomes feedback from
the surgeon community to help improve our products and offer patients the
best in musculoskeletal care."

The 11th EFORT Congress will be held in association with the Spanish
Orthopaedic and Traumatology Society (SECOT) and will include symposia and
instructional lectures as well as industry and technical presentations
covering a range of contemporary orthopaedic and traumatology trends.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs,
develops, manufactures and markets orthopaedic reconstructive, spinal and
trauma devices, dental implants, and related surgical products. Zimmer has
operations in more than 25 countries around the world and sells products in
more than 100 countries. Zimmer's 2009 sales were approximately
US$4.1 billion. The Company is supported by the efforts of more than 8,000
employees worldwide.

(1) The Swedish Knee Arthroplasty Register - Annual Report - Dept. of
Orthopedics, Lund University Hospital: 2009 - ISBN 978-91-976020-9-9 - Page
30, 2008 - ISBN 978-91-976020-0-6 - Page 26, 2007 - ISBN 978-91-976019-5-5 -
Page 24, 2006 - ISBN 91-976019-0-X (Swedish version) - Page 20, 2005 - Page
17

For more information about Zimmer, visit www.zimmer.com

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995
based on current expectations, estimates, forecasts and projections about the
orthopaedics industry, management's beliefs and assumptions made by
management. Forward-looking statements may be identified by the use of
forward-looking terms such as "may," "will," "expects," "believes,"
"anticipates," "plans," "estimates," "projects," "assumes," "guides,"
"targets," "forecasts," and "seeks" or the negative of such terms or other
variations on such terms or comparable terminology. These statements are not
guarantees of future performance and involve risks, uncertainties and
assumptions that could cause actual outcomes and results to differ
materially. For a list and description of such risks and uncertainties, see
our periodic reports filed with the U.S. Securities and Exchange Commission.
We disclaim any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise, except as may be set forth in our periodic reports.
Readers of this document are cautioned not to place undue reliance on these
forward-looking statements, since, while we believe the assumptions on which
the forward-looking statements are based are reasonable, there can be no
assurance that these forward-looking statements will prove to be accurate.
This cautionary statement is applicable to all forward-looking statements
contained in this document.

Media - Sabine Ciccotosto, +41 (0)52-262-72-41, sabine.ciccotosto at zimmer.com; or Paul Blair, +1-574-371-8042, paul.blair at zimmer.com; Investors - James T. Crines, +1-574-372-4264, james.crines at zimmer.com